Martin Lehr Email

Co-Founder and CEO . Context Therapeutics

Current Roles

Employees:
13
Revenue:
$2M
About
Context Therapeutics is a clinical-stage biopharmaceutical company dedicated to creating new medicines to treat female hormone-dependent cancers. Context’s lead program is onapristone extended release (ONA-XR), an investigational Phase 2 drug that is being developed for progesterone receptor positive (PR+) breast, endometrial, and ovarian cancers.
Context Therapeutics Address
3675 Market Street
Philadelphia, PA
United States

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.